Patents by Inventor Andrew Cornforth

Andrew Cornforth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antigen presenting cancer vaccine
    Patent number: 9555058
    Abstract: The disclosure provides reagents, methods, and kits, for treating melanoma. The reagent encompasses interferon-gamma (IFN-gamma) responsive melanoma cells, where the cells are autophagic and non-apoptotic melanoma cells, and where the cells express MHC Class II. In another aspect, the reagent encompassed dendritic cells loaded with the IFN-gamma responsive, non-apoptotic, MHC Class II-expressing melanoma cells.
    Type: Grant
    Filed: October 22, 2012
    Date of Patent: January 31, 2017
    Assignee: Neostem Oncology, LLC
    Inventors: Andrew Cornforth, Robert Dillman
  • Bioreactor Cartridge and System
    Publication number: 20150322397
    Abstract: A bioreactor with a removable reactor core having internal growth chambers, a first end with an inlet upstream from said core; a second end downstream with an outlet from said core; and, a pumping means to provide media flow, is disclosed.
    Type: Application
    Filed: June 18, 2013
    Publication date: November 12, 2015
    Inventors: Andrew Cornforth, Gabriel Nistor
  • Rapid Method Production High Purity Cancer Stem Cells and Population of High Purity Cancer Stem Cells
    Publication number: 20150238586
    Abstract: The disclosure provides reagents, including cells, and related methods, useful for administering to subjects with a neoplastic disorder. The reagents and methods encompass cancer stem cells of enhanced purity. Neoplastic disorder encompasses melanoma, ovarian cancer, colorectal cancer, breast cancer, and lung cancer.
    Type: Application
    Filed: August 6, 2013
    Publication date: August 27, 2015
    Inventors: Andrew Cornforth, Michael McGary
  • PLURIPOTENT GERM LAYER ORIGIN ANTIGEN PRESENTING CANCER VACCINE
    Publication number: 20150064217
    Abstract: The disclosure provides reagents, methods, and kits, for treating or preventing cancers derived from each of the germ layers (endoderm, mesoderm, ectoderm, neural crest). The reagent encompasses interferon-gamma (IFN-gamma) responsive cancer cells, where the cells are autophagic and non-apoptotic cancer cells, and where the cells express MHC Class II.
    Type: Application
    Filed: January 31, 2013
    Publication date: March 5, 2015
    Inventors: Andrew Cornforth, Robert Dillman
  • ANTIGEN PRESENTING CANCER VACCINE
    Publication number: 20140314814
    Abstract: The disclosure provides reagents, methods, and kits, for treating melanoma. The reagent encompasses interferon-gamma (IFN-gamma) responsive melanoma cells, where the cells are autophagic and non-apoptotic melanoma cells, and where the cells express MHC Class if. In another aspect, the reagent encompassed dendritic cells loaded with the IFN-gamma responsive, non-apoptotic, MHC Class II-expressing melanoma cells.
    Type: Application
    Filed: October 22, 2012
    Publication date: October 23, 2014
    Inventors: Andrew Cornforth, Robert Dillman
  • ANTIGEN PRESENTING CANCER VACCINE WITH GAMMA INTERFERON
    Publication number: 20140308316
    Abstract: The disclosure provides reagents, methods, and kits, for treating melanoma. The reagent encompasses interferon-gamma (IFN-gamma) responsive melanoma cells, where the cells are autophagic and non-apoptotic melanoma cells, and where the cells express MHC. Class II. In another aspect, the reagent encompassed dendritic cells loaded with the IFN-gamma responsive, non-apoptotic, MHC Class II-expressing melanoma cells.
    Type: Application
    Filed: October 22, 2012
    Publication date: October 16, 2014
    Inventors: Andrew Cornforth, Robert Dillman